Snippet Search

Searching 12,245,596 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 3461 matching articles

Results per page:

... from colorectal and appendiceal cancer.  Mitomycin 
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Speeten, Kurt; Stuart, O. Anthony; Chang, David; Mahteme, Haile; Sugarbaker, Paul H.
C is a drug often used in this clinical ...
... surface. Most protocols use single agents (  mitomycin 
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Cohen, Mark S.; Al-kasspooles, Mazin F.; Williamson, Stephen K.; Henry, David; Broward, Melinda; Roby, Katherine F.
C or oxaliplatin) provided IP. ...
... the authors report doxorubicin and  mitomycin 
Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis
Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis
Shukla, Anil Kumar; Patra, Sanjukta; Dubey, Vikash Kumar
C, known antitumor agents, as novel ...
... contrast results using two chemoperfusates:  mitomycin 
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Blackham, Aaron U.; Shen, Perry; Stewart, John H.; Russell, Gregory B.; Levine, Edward A.
and cisplatin. ...
... of women remains complicated. We considered  mitomycin 
Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation
Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation
Moiseyenko, Vladimir M.; Chubenko, Vyacheslav A.; Moiseyenko, Fedor V.; Zhabina, Albina S.; Gorodnova, Tatiana V.; Komarov, Yuri I.; Bogdanov, Alexey A.; Sokolenko, Anna P.; Imyanitov, Evgeny N.
C for heavily pretreated hereditary OC ...
... treated with hyperthermic intraperitoneal  mitomycin 
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Sugarbaker, Paul H.; Stuart, O. Anthony; Carmignani, C. Pablo
C chemotherapy after a complete ...
... approach using chemotherapeutic agent  mitomycin 
Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells
Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells
Kim, Seog-Young; Lee, Dae-Hee; Song, Xinxin; Bartlett, David L.; Kwon, Yong Tae; Lee, Yong J.
C, biologic agent tumor necrosis ...
... kann eine Frühinstillation mit 40 mg  Mitomycin 
Harnblasenkarzinom
Harnblasenkarzinom
Dorp, F.; Eisenhardt, A.; Goebell, P.-J.; Gschwend, J.; Jakse, G.; Jäger, T.; Jocham, D.; Karl, A.; Knüchel Clarke, R.; Krege, S.; Lümmen, G.; Ohlmann, C.; Olbricht, T.; Otto, T.; Rettenmeier, A.; Rübben, H.; Schenck, M.; Schmid, K.W.; Stief, C.; Stöckle, M.; Tritschler, S.; Zaak, D.
 C/50 ml NaCl durchgeführt werden. ...
... intravesical regimen that includes both  mitomycin 
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
Hayne, Dickon; Stockler, Martin; McCombie, Steve P.; Chalasani, Venu; Long, Anne; Martin, Andrew; Sengupta, Shomik; Davis, Ian D.
and BCG. ...
... various chemotherapeutic drugs, such as  mitomycin 
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
Braam, H. J.; Hoogwater, F. J. H.
or cisplatin, are used for HIPEC. ...
... administered as a combination therapy with  mitomycin 
Preclinical antitumor activity of a nanoparticulate SN38
Preclinical antitumor activity of a nanoparticulate SN38
Al-kasspooles, Mazin F.; Williamson, Stephen K.; Henry, David; Howell, Jahna; Niu, Fengui; Decedue, Charles J.; Roby, Katherine F.
C was more effective than the combination ...
... technique, we administered hyperthermic  mitomycin 
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Tuttle, Todd M.; Zhang, Yan; Greeno, Edward; Knutsen, Amy
C into the peritoneal cavity for 90 min. ...
... To measure the clearance intraperitoneal  mitomycin 
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Lima Vazquez, Vinicius; Stuart, O. Anthony; Mohamed, Faheez; Sugarbaker, Paul H.
C and doxorubicin in patients having ...
... radiotherapy with capecitabine and  mitomycin 
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma
Stojanovic, Suzana; Popov, Ivan; Radosevic-Jelic, Ljiljana; Micev, Marjan; Borojevic, Nenad; Nikolic, Vladimir; Krivokapic, Zoran; Kecmanovic, Dragutin; Gavrilovic, Dusica; Kezic, Iva
C in patients with locally advanced rectal ...
... each for thiotepa, doxorubicin, and  mitomycin 
Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor
Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor
Rosoff, James S.; Keane, Thomas E.
. ...
... of sequential intravesical gemcitabine and  mitomycin 
Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial
Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial
Jayant, Kumar; Kumar, Santosh; Singh, Shrawan kumar; Agrawal, Swati; Agrawal, Rajendra
C with ...
... von mindestens 50 Gy, 2 Zyklen 5-FU und  Mitomycin 
Radio- und Radiochemotherapie des Analkarzinoms
Radio- und Radiochemotherapie des Analkarzinoms
Zimmermann, F.
C) hat sich im Rahmen zahlreicher Studien ...
... aktivierte Medikamente wie die Alkylantien  Mitomycin 
Kombination von Zytostatika mit Strahlentherapie: Radiochemotherapie
Kombination von Zytostatika mit Strahlentherapie: Radiochemotherapie
Gencer, D.
C und Porfiromycin sowie Cisplatin und ...
... contained in the classical aminoquinones (  mitomycin 
DNA Damaging Drugs
DNA Damaging Drugs
Weber, Georg F.
C, porfiromycin, KW-2149, streptonigrin), ...
... received intravesical chemotherapy (either  mitomycin 
Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
Lammers, Rianne J. M.; Hendriks, Jan C. M.; Rodriguez Faba, O. Rodriguez Faba; Witjes, Wim P. J.; Palou, Joan; Witjes, J. Alfred
C or epirubicin). ...
... Häufig verwendete Chemotherapeutika sind  Mitomycin 
Intraoperative Chemotherapie
Intraoperative Chemotherapie
Feist, M.; Smith, J.; Enkelmann, S.; Hommel, K.; Brandl, A.; Rau, B.
 C, Cisplatin, Oxaliplatin und Doxorubicin ...
... Niereninsuffizienz i.v., i.m., oral  Mitomycin 
Grundlagen der systemischen Therapie
Grundlagen der systemischen Therapie
Schuler, M.; Jäger, T.; Meiler, J.; Gauler, T.; Krege, S.; Rübben, H.
C ...
... cell functions. We report that bleomycin,  mitomycin 
A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents
A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents
Mabeta, Peace; Pepper, Michael S.
C and cytoskeletal-disrupting drugs ...
... Older radiosensitizer agents  Mitomycin 
Radiosensitizers in cervical cancer. Cisplatin and beyond
Radiosensitizers in cervical cancer. Cisplatin and beyond
Candelaria, Myrna; Garcia-Arias, Alicia; Cetina, Lucely; Dueñas-Gonzalez, Alfonso
C ...
... led to the first reports of HIPEC using  mitomycin 
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Mehta, Akash M.; Huitema, Alwin D. R.; Burger, Jacobus W. A.; Brandt-Kerkhof, Alexandra R. M.; Heuvel, Sander F.; Verwaal, Victor J.
C for patients with peritoneal ...